Your future Alzheimer's risk could be prevented
About 1,600 people at high risk of Alzheimer's will take a new drug called trontinemab in trials across the world. Scientists hope the monthly infusion, made by Swiss firm Roche, will prevent symptoms by removing brain plaques more effectively. Trontinemab could lead to Alzheimer's being treated preventively, similar to heart disease medications.
Lost in this story? That's the point of BriefTea.
Open it in the app and tap Learn from this — the Knowledge Galaxy turns the story into a map of everything it assumes you know, one tap at a time. Free, no ads, no paywall.
Get BriefTea on the App Store